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ABSTRACT
Background Reconstruction of the jaws due to resorption of the alveolar crest may require bone 
augmentation for placement and integration of endosseous implants and future rehabilitation with  a 
prosthetic supra-construction. Autogenous bone grafts from the iliac crest have frequently been used 
for this purpose in oral and maxillofacial surgery. Experimental studies have shown stronger bone 
tissue responses to surface-modified implants than to implants with machined surfaces and a 
delayed surgical protocol has been recommended. Whether surface modification of dental implants 
enhances osseointegration in grafted bone and how far the remodeling and resorption process of the 
grafted bone continue, has been a matter of debate.
Aims The aim of the first two studies was to analyse the effect of surface modification of dental 
implants installed in grafted bone. In Study I, surface-modified (test) implants were compared with 
non-modified (control) implants in autogenous bone grafts with regard to osseointegration and 
stability  in terms of bone-to-implant contact (BIC) and resonance frequency analysis (RFA). The 
aim of Study II was to evaluate osseointegration and stability of surface-modified implants in one-
stage (test) vs. two-stage (control) surgery protocols using the same histomorphometric analysis and 
stability  measurements as in the previous study. Study III focuses on differences in marginal bone-
level alterations between autogenous particulate (test) and block (control) onlay  grafts. Stability 
measurements were also studied using RFA. Finally, the objective of Study IV was to examine 
changes in volume reduction of grafted bone. Furthermore, we wanted to compare the amount of 
resorption between particulate bone (test) and block bone (control) grafts. 
Materials & Methods In Study  I, we used eight rabbits. A bone graft from each side of the 
sagittal suture in the calvarial bone was harvested and fixed bicortically  to each proximal tibial 
metaphysis through a dental implant with a blasted, fluoridated (test) surface and a machined 
(control) surface. Test and control sides were randomized. After 8 weeks, the rabbits were sacrificed 
for light microscopic analysis. Resonance frequency analysis was performed both at the time of 
surgery and at the end of the study. 
In Study II, six rabbits were subjected to the same bone grafting procedure; however, only implants 
with blasted, fluoridated surfaces were used in fresh (test) and healed (control) bone grafts. The 
healing time before stage two surgery was 8 weeks, with another 8 weeks between stage two 
surgery and sacrifice. The specimens were studied by light microscopic analysis and RFA was 
performed both at the time of surgery and at the end of the study. 
Study III included 15 patients who had undergone reconstruction of the maxillary alveolar bone 
with autogenous bone grafts from the iliac crest, particulate (test) grafts on one side and block 
(control) grafts on the contralateral side. Six months after the grafting procedure, surface-modified 
dental implants with titanium dioxide were installed. After an additional 6 months, abutments were 
placed in all cases. As a parallel intra-oral technique, radiographs were taken to measure the 
marginal bone level at baseline (after completion of the prosthetic treatment), after 1 year and again 
after 5 years of loading. Resonance frequency analysis was conducted after fixture installation, at 
abutment connection, and after 1 and 3 years.
Study IV included eleven patients from the same group as included in Study  III. Radiographic 
examinations using computed tomography (CT) were carried out within 1 month of the grafting 
procedure, and after 6 months and 24 months in function. 
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Results Study I shows that implants with blasted, fluoridated surface (test side) achieve greater 
osseointegration and stability  in terms of BIC and RFA results. In Study II, no statistically 
significant difference could be observed in osseointegration between test  and control sides. The 
RFA appeared to be higher at implant placement in favour of the two-stage surgery protocol, but the 
difference was levelled out by  the time of sacrifice. Study III showed a tendency  for more marginal 
bone resorption on the control side augmented by block bone grafting at baseline and after 1 and 5 
years of loading, but the difference was not statistically significant. In addition, no significant 
difference in RFA could be observed between the test and control sides at any time. Study IV 
showed that the volume reduction on both the test and the control side was extensive after 6 
months. Further volume reduction could be observed at the 2-year follow-up. At the particulate 
(test) side, 81.1% resorption could be observed, while on the control side augmented by block 
grafting, the resorption rate was 77.8%. The difference between test  and control sides was not 
statistically  significant. Despite major resorption of the augmented bone, no implant losses were 
occurred.
Conclusion This thesis shows that greater osseointegration can be achieved when using 
fluoridated, moderately  rough titanium implants in augmented bone during the healing period 
compared with non-modified implants. In our material, there was no difference in marginal bone 
loss whether implants were placed in block or particulate bone. Volume changes in autogenous 
block or particulate bone from the iliac crest showed no significant difference in resorption. Most of 
the resorption took place during the first 6 months of healing. Although the resorption continued 
after 6 months, implants remained imbedded and stable in the grafted bone. 
Key words autogenous bone graft, experimental study, radiographic study, surface-modified 
implants
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INTRODUCTION
Background
Autogenous bone grafts are frequently used in cranio-maxillofacial and orthopaedic 
surgery. Data in the scientific literature regarding maturation and resorption of 
autogenous onlay bone grafts are sparse.
Edentulism is a matter of discomfort in terms of both aesthetics and loss of functional 
ability. Although the rate of edentulism has declined in some European countries1, the 
expectation of better masticatory ability has increased among patients, perhaps 
because of the development of implant dentistry. Initial implant research was 
performed by  Brånemark and co-workers2. When the term “osseointegration” was 
coined in 19773, osseointegration was more a concept than a precisely defined 
biological term4. In 1985, Brånemark et al.5 provided a scientific definition of the 
term. 
Figure 1. Lateral view of a resorbed maxilla
Rehabilitation of edentulous jaws with 
endosseous implants has been performed 
for more than 3 decades. Although many 
edentulous patients have been treated 
with endosseous implants with fixed oral 
prostheses, there is a patient group in 
whom fixed restorations with endosseous 
implants remain a challenge because of 
inadequate residual bone volume both in 
width and in vertical dimensions. To 
achieve primary stability as well as 
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longevity of endosseous implants, bone grafting may be inevitable. Many grafting 
materials and procedures have been tested and documented in the literature, with 
varying clinical outcomes6–11, but in patients with large areas of resorption, especially 
within the maxilla, autogenous bone grafts have been regarded as a treatment with 
predictable and successful results12,13. 
The disadvantages of using autogenous bone grafts have been discussed in the 
literature, mostly being various donor site morbidities14. The most common reported 
post-surgical sequels for bone grafts from the iliac crest are: gait disturbance15–19, 
infection15, haematomas15, altered sensation along the course of the lateral femoral 
cutaneous nerve15,17, stress fracture15 and even meralgia paraesthetica15, to name a 
few. The advantages, on the other hand, are the graft’s ability to be both 
osteoconductive and osteoinductive20,21. Besides functioning as space holders and 
scaffolding for new bone formation in sinus floor augmentation, autogenous bone 
grafts have proved to function as lateral onlays for increasing the width of a resorbed 
alveolar crest22–24. Autogenous bone blocks have also been used as interpositional 
bone grafts to correct large sagittal discrepancies after a LeFort I down fracture of the 
maxilla25,26. Therefore, this augmentation procedure has been an issue for research 
over many years. However, one of the greatest challenges that the surgeons are faced 
with is the amount of resorption that takes place after the grafting procedure, at least 
when the aim is to gain greater width of the alveolar crest for optimal implant 
positioning. Johansson et al.27 have for example reported a decrease in bone volume 
of 47% for buccal onlays after 6 months. 
Since surface modification of dental implants was first attempted, higher implant 
survival rates have been reported in clinical studies. Histological studies have also 
reported greater bone-to-implant contact (BIC), with higher implant stability28. 
However,  most of these studies were conducted in patients with implants embedded 
in their residual bone. Furthermore, in bone grafting procedures using autogenous 
bone grafts from the iliac crest, a two-stage protocol has been recommended29,30. One 
of the issues to be addressed is whether surface-modified dental implants present 
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greater BIC and higher implant stability in comparison with implants with machined 
surfaces when placed in autogenous bone blocks? And if so, could surface-modified 
implants achieve enough BIC and implant stability when placed simultaneously in a 
grafted bone, as in a delayed approach? In addressing these issues, there is a need to 
study osseointegration of implants with rough surfaces when placed in autogenous 
bone grafts. Furthermore, since autogenous bone grafts are frequently used as lateral 
onlays, a relatively long-term follow-up of grafted bone and its interaction with 
surface-modified implants is needed.
Bone
Origin and function
Bone is a connective tissue that consists of cells and extracellular matrix. The 
craniofacial skeleton is formed from the neural crest cells31. In regions of the 
craniofacial skeleton, differentiation into osteoblasts produces intramembranous (IM) 
bones directly, while differentiation into chondrocytes produces a framework of 
cartilage models of the future bones in the remaining skeleton. These cartilage 
models are subsequently replaced by bone and bone marrow through the process of 
endochondral (EC) ossification31. The principal role of the skeleton is to provide 
structural support for the body. It opposes muscular contraction resulting in motion, 
withstands functional load and protects internal organs32. Furthermore, bone 
functions as a site for haemopoiesis, and a reservoir for calcium storage and ion 
homeostasis33.
Bone cells 
Bone cells constitute about 10% of total bone volume34. They arise from two different 
cell lines: osteoprogenitor cells arise from mesenchymal stem cells that differentiate 
into osteoblasts and osteocytes. Whereas osteoclasts are of hematopoietic origin35,36. 
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The osteoblast
Osteoblasts line the surface of bone and pack tightly against each other. When active, 
they have a rounded, oval polyhedral form and an osteoid seam separates them from 
the mineralized matrix36. Osteoblasts are the only cells with capability of bone 
formation37. They synthesize both the collagen and the ground substance that 
constitutes the initial unmineralized bone or osteoid38. Type I collagen is the major 
protein in the matrix. Its fibres provide the structure on which mineral is deposited39. 
Non-collagenous proteins that constitute the ground substance are proteoglycans and 
glycoproteins40.
Osteoblasts are also responsible for calcifying the matrix through secretion of small 
membrane-limited matrix vesicles that accumulate calcium and phosphate38,41. In 
addition, osteoblasts are responsible for regulating the differentiation of the bone-
resorbing osteoclasts39. Osteoblasts produce the receptor activator NF-ĸB ligand 
(RANKL), a cell surface protein. It binds to the receptor (RANK) on the surface of 
mononuclear osteoclast precursors which fuse to form multi-nucleate osteoclasts39,42. 
Some factors that act on osteoblasts to increase RANKL expression are: parathyroid 
hormone (PTH), PTH-related peptide (PTHrP), tumour necrosis factor alpha (TNF-α) 
and interleukin (IL)-1 (IL-1)37,43–47. Four maturational stages have been identified in 
osteoblast differentiation: pre-osteoblast, osteoblast, osteocyte and bone lining cells. 
Once the appropriate stimulus is present, the mesenchymal stem cells turn into pre-
osteoblasts37. Histologically, these cells resemble osteoblasts; however, they lack 
some of the characteristics of mature osteoblasts including the ability to produce 
mineralized tissue48. Mature osteoblasts face one of three fates: they either undergo 
apoptosis, or differentiate into osteocytes, or become  quiescent lining cells37,49,50. 
The osteocyte
Osteocytes are cells which have been differentiated from osteoblasts and are 
embedded in the bone matrix51. They are the most numerous specialized bone cell 
type in mammalian bone and are found within individual lacunae in the mineralized 
bone matrix52. Osteocytes are smaller than osteoblasts and have lost many of their 
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cytoplasmic organelles53. Once embedded in the osteoid, they start to extend dendritic 
projections51. These dendritic projections extend through channels in the bone matrix, 
called canaliculi54,55, and help the osteocyte to be in communication with already 
imbedded cells and other bone cells on the bone surface51, such as bone lining cells 
and osteoblasts52. The function of osteocytes is to maintain the bone matrix33 and to 
function as mechanosensors56,57. Osteocytes do not normally express alkaline 
phosphatase, but they express several matrix proteins that facilitate intercellular 
communication and regulate the mineral exchange in the bone fluid within the 
lacunae and canaliculi system35. It is through the intercellular communication 
network between bone lining cells, osteoblasts and osteocytes that mechanical strains 
can be translated into electric fields in the cells which can induce osteogenic 
stimulus58. 
Bone lining cells
Bone lining cells are cells that are closely apposed to the bone surface. They are thin, 
and have a flat nuclear profile with a cytoplasm that is extended through the bone 
surface. Gap junctions exist between bone lining cells and osteocytes. It has been 
proposed that bone lining cells act as a functional membrane, separating bone fluids 
from interstitial fluids59, and are responsible for the immediate release of calcium 
from bone when the blood calcium level is low60. When exposed to PTH, bone lining 
cells secrete enzymes that remove the osteoid layer covering the mineralized 
matrix61.
The osteoclast
Osteoclasts are giant, multi-nucleated cells and are the only cell type that can resorb 
bone62. According to Lerner62, when mononucleated osteoclast precursor cells that 
are derived from stem cells in the hematopoietic tissues enter circulation, they 
migrate to the fibrous part of the periosteal tissues. At the same time, osteoblasts that 
are in the periosteum form a one-cell layer covering the mineralized bone. 
Osteoblasts express receptors for hormones and cytokines. Activation of these 
receptors by hormones such as PTH results in a new phenotype of the osteoblast, 
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causing osteolytic degradation of the osteoid layer which is a zone of unmineralized 
osteoid separating osteoblasts from the mineralized bone. Next follows a paracrine 
stimulation of the osteoclast precursor cells which further proliferate, differentiate 
and fuse to latent osteoclasts. Finally, the osteoblasts withdraw from the non-osteoid, 
covered mineralized bone and the latent osteoclasts that are activated by osteoblasts 
migrate and attach to the mineralized bone surface and initiate the resorptive process.
The further differentiation from the osteoclast progenitor cell into the osteoclast is 
also controlled by macrophage colony-stimulating factor (M-CSF), osteoclast 
differentiation factor (ODF) and osteoprotegerin (OPG), to name a few. These factors 
are expressed by cells in the hematopoietic tissues and act as activator/inhibitor of 
osteoclast formation62,63.
Figure 2. Cells responsible for bone remodeling
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The extra-cellular matrix
The extra-cellular matrix composes about 90% of the total bone volume34. It consists 
of 50–70% inorganic or mineral matrix, about 20–40% organic matrix, 5–10% water 
and <3% lipids35. 
The mineral content of bone is mostly in the form of hydroxy-apatite (HA) crystals
[Ca10(PO4)6(OH)2] and because they are smaller and less perfect in structure than 
naturally occurring apatites, they are more reactive and soluble32,. While the 
inorganic matrix provides mechanical rigidity and load-bearing strength, the organic 
matrix provides elasticity and flexibility to bone35. 
The organic matrix of bone consists largely of type I collagen34,35 which is fibril-
forming. Fibril-associated collagens with interrupted triple helix (FACIT collagens) 
are a group of non-fibrillar collagens that serve as molecular bridges, thus 
establishing organization and stability of the extracellular matrix35. The molecular 
conformation of the collagen triple helix confers strict amino acid sequence 
constraints64. There are also non-collagenous proteins in the extracellular matrix, 
such as osteocalcin, osteopontin and bone sialoprotein. It is believed that these 
calcium- and phosphate-binding proteins help regulate the amount and size of the 
HA crystals35.
Bone structure
Bone can adapt to functional loading conditions and has a great potential to heal. 
Bone is composed of a cortical (compact) dense layer that forms the outside of the 
bone tissue while centrally, a cancellous (trabecular or spongy) arrangement of thin, 
inter-communicating spicules form a meshwork. Long bones consist also of bone 
marrow, which consists of hematopoietic tissue and fat cells. Mature cortical bone 
consists of cylindrical systems of bone structure, called “osteons” or “Haversian 
systems”. The Haversian canals are surrounded by concentric lamellae that run 
parallel to each other. There are also interstitial lamellae between every osteon. 
Haversian canals are in contact with each other through Volkman’s canals, which are 
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channels in lamellar bone containing blood vessels and nerve fibres. Cortical bone is 
highly mineralized and is more rigid than cancellous bone, which consists mostly of 
bone marrow. Mineralized bone can be distinguished as woven or lamellar. Woven 
bone is formed at an early stage of bone formation, and consists of irregularly packed 
collagen fibres, large osteocyte lacunae, and minerals. As the mineralization process 
proceeds, this softer bone is replaced by lamellar bone, which has an organized 
structure.
Bone formation and remodeling
 As mentioned previously, bone develops via two different mechanisms: IM and EC 
bone formation. In IM bone formation, mesenchymal stem cells differentiate directly 
into osteoblasts and proceed to form bone by mineralization of an organic matrix. 
This process forms the facial bones and the vault of the skull65. Endochondral bone 
formation occurs when mesenchymal cells proceed via chondrocytes, which form 
cartilaginous templates for the future bones. The long bones, pelvis, vertebrae and 
base of the skull are formed via EC bone formation65. Throughout life, the bone is 
continuously remodelled. This remodelling procedure involves replacement of woven 
bone by lamellar bone and also a continuous remodeling process in which 
replacement of mature lamellar bone takes place through osteoclastic and osteoblastic 
activities66. 
The regulation of bone remodelling is both systemic and local66. The major systemic 
regulators are the two major calcium-regulating hormones PTH and 1,25-dihydroxy 
vitamin D. Parathyroid hormone is a potent stimulator of bone resorption and has a 
biphasic effect on bone formation67. It stimulates bone formation when given 
intermittently and bone resorption when secreted continuously66,67.  Furthermore, 
PTH and vitamin D in high doses decrease collagen synthesis67. Calcitonin can 
inhibit bone resorption but appears to play little role in the regulation of the 
physiologic calcium level in adult humans. However, it is a potent inhibitor of bone 
resorption and is used clinically in the treatment of osteoporosis67. Growth hormone 
(GH), acting through both systemic and local insulin-like growth factor (IGF) 
16
production, stimulates bone formation and resorption67. The GH/IGF-1 system and 
IGF-2 are important for skeletal growth, especially at the cartilaginous templates and 
plates and during EC bone formation. They are among the major determinants of the 
bone mass through their effect on regulation of both bone formation and resorption66. 
Glucocorticoids are necessary for bone cell differentiation during development, but 
their post-natal effect is to inhibit bone formation67. Thyroid hormones stimulate both 
bone resorption and formation66. Probably the most important systemic hormone in 
maintaining normal bone turnover is estrogen67. Estrogen deficiency leads to an 
increase in bone remodelling, in which resorption exceeds formation and bone mass 
decreases. This can be observed, not only in post-menopausal women but also in men 
with defects in either oestrogen receptor or the synthesis of oestrogen from 
testosterone67.
Local regulators of bone remodelling are cytokines, prostaglandins and growth 
factors. Cytokines that cause bone loss are IL-1, TNF and ODF. There are some 
cytokines that prevent bone loss, such as IL-4 and OPG67. Bone remodelling also 
involves proteins that are responsible for the interaction between cells of the 
osteoblastic and the osteoclastic lineage67. These proteins belong to the family of 
TNF receptors. Osteoblast precursors express a molecule called “TNF activation-
induced cytokine (TRANCE)”, also known as “RANKL”68. As described earlier, 
RANKL, expressed on the surface of preosteoblastic cells, binds to RANK on the 
preosteoclastic precursor cells and is critical for the differentiation, fusion into multi-
nucleated cells, activation, and survival of osteoclastic cells66.
Osteoclastic resorption produces irregular, scalloped cavities on the trabecular bone 
surface, called “Howship lacunae”, and cylindrical Haversian canals in cortical bone. 
These cavities are finally filled by new bone from osteoblasts67. Rasmusson69 refers 
to the cells responsible for this osteoclastic/osteoblastic activity, as cutting and filling 
cones in cortical bone, and as bone-metabolizing units (BMUs) in trabecular bone, a 
term first coined by Frost70 in 1963. Terms such as “basic multicellular unit” and 
“basic metabolizing unit” have also been used in the literature, referring to the same 
specialized group of cells71. Bone resorption followed by bone formation was 
17
referred to as a “creeping substitution” by Albrektsson72, a process which results in 
secondary osteon formation in which a resorption canal is formed by osteoclasts. The 
osteoblasts then refill these canals with concentric lamellae69. Primary osteon 
formation appears during the appositional bone growth from the perimeter towards 
the Haversian canals. 
Bone repair
The mechanisms of IM and EC bone formation also apply to bone repair following 
fractures or osteotomies73. The three stages of normal wound healing of soft tissue, 
the inflammatory stage, fibroblastic stage and remodeling stage, are also present in 
the normal wound healing of bone tissues, with a some modification due to the 
presence of osteoblasts and osteoclasts74. Shapiro73 describes bone healing as 
following one of four different patterns:
1. Endochondral bone repair (a repair by callus formation), mediated by the inner 
periosteal layer and marrow tissue, synthesizing first cartilage and then woven 
and lamellar bone. This form of bone repair takes place in an environment of 
inter-fragmentary space and mobility.
2. Primary bone repair (direct contact repair) is mediated by osteoclasts and 
osteoblasts from the intraosseous Haversian system without a cartilage phase. 
Primary bone repair occurs strictly within the cortex in situations where 
fractures or osteotomies are rigidly compressed with no inter-fragmentary gap, 
causing repair to occur via initial lamellar bone deposition already parallel to the 
longitudinal axis of the bone.
3. Direct bone repair is also mediated without a cartilage phase by marrow-derived 
vessels and mesenchymal cells perpendicular to the long axis of bone in an 
inter-fragmentary space with rigid stability. The gap is >0.1 mm; however, in 
such dimensions, repair can occur without cartilage mediation. The bone 
originates from the marrow cells and is aligned at right angles to the long axis of 
the bone. Therefore, it must undergo remodelling to align the lamellar bone to 
the longitudinal axis of the bone.  
18
4. Distraction osteogenesis is the fourth pattern of bone healing and is mediated by 
an inner periosteal layer and marrow tissue including endosteal tissue 
synthesizing woven and lamellar bone in a slowly widening gap.
According to Hing75, any fractured bone heals through EC ossification in a five-step 
process:
1. A haematoma is formed in response to an injury to the periosteum, which is a 
fibrous membrane containing blood vessels.
2. Due to this disruption of the blood supply, the osteocytes nearest to the fracture 
die, resulting in local necrosis of the bone tissue around the fracture.
3. Because of the necrotic tissue, macrophages and fibroblasts are recruited to the 
damaged site, to remove tissue debris and express extracellular matrix, 
respectively. In response to growth factors and cytokines released by 
inflammatory cells, mesenchymal cells are recruited from the bone marrow and 
the periosteum then proliferates and differentiates into osteoprogenitor cells.
4. This results in thickening of the periosteum and production of external callus 
around the fracture site. Those osteoprogenitor cells that are close to undamaged 
bone and lie within the reach of the oxygen supply differentiate into osteoblasts 
and form osteoid, which is rapidly calcified into bone, while those farther away 
turn into chondroblasts and form cartilage. Angiogenesis is induced and as soon 
as the cartilage has been formed and the fracture site is stabilized, it is replaced 
by woven cancellous bone via EC ossification in which osteoclasts and 
osteoprogenitor cells invade the cartilaginous callus.
5. The woven bone is then remodeled to lamellar bone and the process is 
completed by the return of normal bone marrow within cancellous regions, 
while in repairing cortical bone, the spaces between trabeculae are gradually 
filled with successive layers of bone, forming new Haversian canals.
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According to Shapiro73, when a stable environment for repair is established by early 
surgical fixation of the fragments, the need for a large external cartilage callus is 
bypassed. With very rigid fixation, the entire EC sequence can be bypassed and new 
bone can be formed without the interposition of cartilage tissue at all. Furthermore, it 
has been noted by the same author that a slight opening between two bone fragments 
leads to repair of bone without a cartilaginous stage as the slight inter-fragmentary 
space allows for vascular invasion from the marrow cavity along the mesenchymal 
cells, which synthesizes lamellar bone at right angles to the longitudinal axis of 
bone73. Therefore, the presence of oxygen is crucial for direct bone repair. 
The upper limit size of the gap for primary repair of bone has been estimated to be 
about 0.5 mm by some authors and 0.1 mm by others76. In addition, the absence of 
micro-movements is decisive for direct bone repair. According to Philips and Rahn77, 
improved results with respect to graft resorption can be expected if onlay bone grafts 
are stabilized. Hjorting-Hansen et al.78, claim that micro-movements during the early 
healing phases influences cellular differentiation. The authors describe that if the 
distance in healing site is increased by 100% during the very early stages of fracture 
healing, the primitive mesenchymal cells tend to differentiate to fibroblasts rather 
than osteoblasts.
 
In implant dentistry, bone healing is described as contact osteogenesis, which implies 
bone formation in direct contact with the implant surface, and distance osteogenesis, 
meaning new bone formation on the surfaces of the parent bone79. Using Labrador 
dogs, Botticelli and co-workers80 studied the amount of new bone formation adjacent 
to implants placed in recipient sites with a wide marginal defect. They also studied 
the degree of BIC. In each dog, mandibular premolars and first molars were 
extracted. After 3 months of healing, defect preparation and implant installation were 
performed. Implants installed had sandblasted, large-grit, acid-etched (SLA) surface 
treatment (ITI® system; Straumann, Waldenburg, Switzerland). The implants were 3.3 
mm in diameter and 10 mm in length. The defects were 5.3 mm wide and 5 mm deep, 
creating a distance of 1–1.25 mm between the implant and the bone walls. Traditional 
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implant installation was performed in one site as control. The results showed that 
large marginal defects had been filled with newly formed bone after 4 months of 
healing. The degree of BIC at all test sites was similar to that at control sites. 
Furthermore, placement of a barrier membrane did not improve the outcome of 
healing. The authors concluded that marginal defects >1 mm may heal, with new 
bone and a high degree of osseointegration to an implant with an SLA surface80. In 
another experimental study81, implants using SLA surface ITI® system were 
compared with turned implants in defect areas of the same size as described above. 
The results showed significantly greater distance between the implant margin and the 
most coronal level of BIC for the turned implants. It was concluded that surface 
characteristics influence osseointegration of implants placed with marginal defects.
Further experiments82 have shown significantly larger areas of osseointegration for 
OsseoSpeedTM implants with a fluoride-modified surface (test side) compared with 
MicroThreadTM implants with TiOblast surface (control side). Following implant 
installation, a 1 mm wide gap occurred between the implant surface and the bone 
wall. Moreover, specimens obtained after 2 weeks of healing showed that woven 
bone had formed from the apical and lateral areas of the defect on both the test and 
control sides. After 6 weeks of healing, bone formation had continued and bone 
occupied a substantial part of the defect.
Therefore, it appears that in situations with marginal bone defects about 1–1.25 mm 
wide, bone healing may occur and surface modification may play a crucial role in 
osseointegration when placing the implants in defects. 
Healing of autogenous bone grafts
Autogenous bone grafts are considered to be the gold standard because of the lack of 
an immunologic rejection mechanism and the presence of stem cells and growth 
factors, both with osteoinductive and osteoconductive properties83. Because the major 
challenges of bone augmentation with an autogenous bone graft are the graft’s 
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incorporation in the recipient bone tissue and the resulting volume change, a 
thorough understanding of the healing process of the grafted bone is important.
Cortical versus cancellous bone
There are some differences in the histologic events during incorporation of cortical 
vs. cancellous bone84. Cancellous bone is revascularized more rapidly than cortical 
bone, owing to its porous nature, therefore permitting more complete incorporation 
and perhaps even total replacement. It is also believed that new bone formation on 
transplanted trabecular surfaces precedes resorptive activity84,85. In addition, while 
creeping substitution of cancellous bone initially involves an appositional bone 
formation phase followed by a resorptive phase, cortical grafts undergo a reverse 
creeping substitution process. Lastly, cancellous bone tends to repair completely with 
time, while cortical grafts remain a blend of necrotic and viable bone21. However, the 
initial events in the incorporation of a non-vascularized, fresh autogenous cortical 
graft and a cancellous graft are suggested to be identical84. First, a haematoma is 
formed around the grafted bone. Then, necrosis of the graft stimulates an 
inflammatory response which causes the milieu to transform into a fibrovascular 
stroma. This connective tissue conveys blood vessels from the recipient bed and 
osteogenic precursor cells to the graft84. The major contributions from the bone graft 
are space keeping, osteoconduction and osteoinduction84. Osteoconduction is 
characterized by the graft acting as a scaffold on which new bone is deposited while 
the graft itself functions in a passive mode. Osteoinduction occurs when graft-derived 
factors actively stimulate the recipient bone to invade the structure with osteogenic 
activity. The source of stimulation may partially reside with cells in the bone graft but 
most certainly emanate from matrix in the form of bone morphogenic protein 
(BMP)86.
Guided bone regeneration
Guided bone regeneration (GBR) is a surgical method by which the alveolar bone 
volume in areas designated for future implant placement or around previously placed 
implants is augmented87. By a mechanical hindrance, using a membrane technique, 
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fibroblasts and other soft connective tissue cells are prevented from entering the bone 
defect so that the presumably slower migrating cells with osteogenic potential are 
allowed to repopulate the defect88. Four major principles for GBR have been 
described in the literature87: primary wound closure, angiogenesis, space 
maintenance, and stability of the wound and implant.
Cardinal factors for predictable bone regeneration 
The principles mentioned above may also be applied when discussing prerequisites 
for healing of autogenous bone grafts without GBR technique. Cardinal factors for 
predictable bone regeneration include:
✦ The intention of primary wound closure is to place the edge of the wound in the 
same position as prior to the incision. Passive closure of wound edges enables 
the wound to heal with reduced re-epithelialization, collagen formation and 
remodelling, and wound contraction87. Goldstein et al.89 describe some factors 
that must be taken into consideration when managing soft tissues in the oral 
cavity: complete and tension-free flap coverage of the wound, maintenance of 
the vestibule depth and preservation of the keratinized tissue. 
✦ Angiogenesis is a crucial factor for the initial healing process, providing 
nutrient, gas and undifferentiated mesenchymal cells, which enhances bone 
regeneration through newly formed blood vessels90. Several studies have shown 
close correlation between angiogenesis and bone formation91–94. Angiogenesis is 
a multi-step process leading to the formation of new vessels by sprouting from 
pre-existing ones. It involves activation, adhesion, migration, proliferation and 
transmission of endothelial cells across cell matrices to or from new capillaries 
and from existing vessels95. Furthermore, angiogenesis is a process that is highly 
dependent on coordinated production of angiogenesis- stimulatory and 
inhibitory factors95. Schmid et al.94 elaborate on the effect of temporary removal 
of the overlying periosteum during bone surgery, which will cause a tear in 
some small blood vessels extending from the periosteum into the bone, and 
thereby cause some vessel wounding. This wounding, in turn, may be sufficient 
to cause a biological cascade that will end up with new bone formation. This 
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may explain successful bone regeneration without further bone wounding, 
according to the authors. Some authors have described the role of cortical 
perforation of the recipient bed90, proposing that cortical perforation of the 
recipient bed and the autogenous bone block could enhance initial angiogenesis 
and thereby the integration of the graft. 
✦ Space maintenance in the bone grafting procedure relates to the autogenous 
bone graft in the shape of either block or particulate bone, which functions as 
space holder by its very nature while acting as scaffold for new bone formation, 
and also initiating osteogenesis through its osteoinductive ability.
✦ Fixation is another factor that needs to be taken into consideration when 
performing augmentation of the alveolar ridge by means of an autogenous bone 
block. Phillips and Rahn77 report that in their material, the volume of fixed bone 
grafts was significantly higher compared with that of non-fixed grafts after 20 
weeks. La Trenta et al.96 examined the role of rigid skeletal fixation in bone graft 
augmentation of the craniofacial skeleton. Their results showed bony union of 
bone grafts fixed with rigid skeletal fixation, while fibrous union predominated 
in bone grafts fixed with wire technique. 
Different donor sites in jaw bone reconstruction
Various donor sites have been discussed in the literature concerning autogenous bone 
grafts97–100. Local autogenous bone grafts have the advantage of being easy to access. 
The benefits of using local bone grafts are avoidance of a distant surgical site and the 
consequent morbidity101,102. Mandibular bone grafts which have been used for 
alveolar reconstruction have shown favourable results103–105. However, these donor 
sites have anatomical limits. The coronoid process offers limited amount of bone to 
be harvested. The symphyseal area and the mandibular ramus also restrict the amount 
of bone that can be harvested because of anatomical considerations such as tooth 
roots and, in the case of the symphyseal donor site, mental foramina. Third molar 
teeth and the inferior alveolar canal also restrict the amount of bone to be harvested 
when harvesting bone from the mandibular ramus. A rectangular graft from the 
mandibular ramus may approach 3.5 cm in length, while it is not much greater than 1 
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cm in height. These dimensions apply to a span of three to four tooth sites106. 
Therefore, in cases with total tooth loss in the maxilla and severe resorption of the 
alveolar ridge, using autogenous bone grafts from the iliac crest is usually necessary. 
In some patients with severe maxillary atrophy (class V and VI),107 a reversed inter-
maxillary relation or increased vertical distance between the jaws may result108. The 
indication for harvesting autogenous bone block from the ilium becomes more 
evident in these cases, not only for the purpose of optimal implant positioning but 
also for restoring the correct facial height and morphology.
Another aspect regarding the choice of donor site relates to its origin, namely, 
whether the harvested bone has an EC or IM origin. Clinical studies have shown that 
IM onlay bone grafts tend to resorb less compared with EC bone grafts in the 
craniofacial skeleton109,110. Experimental studies likewise have shown more 
favourable results, in terms of volume maintenance, for IM bone grafts111–113. Ozaki 
and Buchman114 point out that in some previous studies115,116, IM bone, owing to its 
ability to maintain volume, has been reported to have inherent embryogenic 
advantage over EC bone. However, the authors then challenge this idea by suggesting 
that the micro-architecture of the IM bone graft has more cortical bone compared 
with EC grafts, and hence that IM bone is less prone to resorption. In that study114, 
cortical bone grafts of membranous origin and cortical and cancellous bone grafts of 
EC origin were compared by placing them onto cranium of rabbits. Volume analysis 
showed a statistically greater resorption rate in the cancellous EC bone graft than in 
either the EC or the membraneous cortical bone grafts. Furthermore, no statistical 
difference was observed in the resorption rates between the two cortical onlay bone 
grafts of different embryonic origin. 
In an experimental study, Kusiak and co-workers117 relate the ability of greater 
volume maintenance of IM bone grafts to more rapid vascularization compared with 
EC bone.
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Smoking
Cigarette smoking may have a negative influence on wound healing118. Bain and 
Moy119 ascribe the negative effects of cigarette smoking on wound healing to the 
direct cutaneous vasoconstrictive action of nicotine, increased platelet aggregation 
and compromised polymorphonuclear (PMN) leucocyte function, to name a few 
causes. Several studies report a correlation between smoking and higher risk of 
implant failure120-124. Based on these findings, smoking could be regarded as a 
contraindication also for bone augmentation. A systemic review of the orthopaedic 
literature regarding the impact of smoking on bone healing has revealed that smoking 
has a negative effect on bone healing in terms of delayed union and non-union125. 
Nicotine decreases blood flow to the extremities owing to the increased peripheral 
vasoconstriction, especially relating to digital and forearm haemodynamics126. 
Furthermore, carbon monoxide has a high affinity for haemoglobin, reducing the 
amount of oxygen carried by this molecule127. Smoking has been reported to be one 
of the predictors of implant failure after maxillary sinus floor augmentation and 
reconstruction128. It has also been reported in the literature that post-operative healing 
complications occur significantly more often in smokers compared with non-
smokers129.
Surgical techniques
Surgical procedure of the reconstruction of the atrophic maxilla can be divided into: 
inlay, onlay, and interpositional bone grafting. In a systemic review article Del 
Fabbro et al.130 report the survival rates of implants in the grafted maxillary sinus as 
follows: the overall implant survival rate in 39 studies was 91.49%. The loaded 
follow-up time ranged from 12 to 75 months. Simultaneous vs. delayed procedure 
displayed almost similar survival rates, of 92.17% vs. 92.93%. Furthermore, when 
implants were installed in grafted maxillary sinus, the performance of rough implants 
was shown to be superior to that of smooth surface implants. Bone substitute material 
proved to be as successful as autogenous bone grafts. In another study131 the use of 
cancellous block allografts for sinus floor augmentation with simultaneous implant 
placement was evaluated, with a mean follow-up of 27 months. The inclusion 
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criterion was a residual alveolar ridge height of ≤4 mm. The success rate was 
reported to be 94.4%. Olson and colleagues132 report a long-term assessment of 
endosseous dental implants in the augmented maxillary sinus. The follow-up began at 
stage two (abutment connection) and ranged from 5 to 71 months. Although the 
amount of residual bone was not measured and recorded, the results showed high 
implant survival rates in grafted sinuses (97.5%). Out of 120 implants placed in 45 
grafted sinuses, 88 implants were placed simultaneously and 32 were placed 3–12 
months after sinus augmentation. The sinus augmentation material did not appear to 
affect the long-term success, from implant placement to loading, or function as 
described by the authors. However, when comparing a one-stage surgery protocol 
with a delayed placement of implants, it appeared that all the failed implants occurred 
when using a one-stage surgery protocol. Based on these studies, it can be concluded 
that when placing an endosseous implant into grafted bone, primary implant stability 
is of utmost importance for osseointegration to take place. Consequently, when 
primary implant stability cannot be achieved, a staged surgery protocol is 
recommended. This approach is also valid when augmenting a resorbed maxillary 
ridge with onlay buccal or vertical bone grafts. However, since this type of bone 
augmentation is more susceptible to lateral and occlusal forces, using a one-stage 
surgery protocol is not as straightforward and conclusive as is a maxillary sinus 
augmentation procedure. 
The onlay group can be divided into horizontal (buccal veneer) grafting and vertical 
grafting. While buccal onlay grafting has been used to augment the width of a 
resorbed maxilla, some clinicians have reported satisfying results also when 
augmenting the height. Nyström et al.133 conducted a study to post-operatively 
evaluate combined use of bone grafts and implants, using computed tomography 
(CT). The harvested bone was from both the lateral and the medial aspect of the 
ilium, forming a horseshoe shape. According to the authors, the graft was then 
modelled to fit the residual maxillary alveolar crest. Using a one-stage surgery 
protocol, six self-tapping fixtures were inserted, penetrating the bone graft and the 
residual bone. Rigid fixation was established. Out of 120 fixtures inserted, 14 were 
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reported lost during the observation period of ≥24 months. Prior to this study, a 2-
year longitudinal study was initiated by Nyström and colleagues134 using the same 
surgical procedure in 30 patients. The first ten patients were classified as the 
development group and the remaining 20 patients as the routine group. The implant 
survival rate after 2 years was reported to be 54.4% in the development group and 
88.3% in the routine group. In a 10-year follow-up study of the same patient group, 
the implant success rate was reported to be 83.1% in the routine group135. Van 
Steenberghe et al.136 report a cumulative success rate of 85% after a 10-year follow-
up when placing implants simultaneously with autogenous onlay bone grafts. The 
bone graft harvested was also in the shape of a horseshoe and was stabilized with 
four to seven self-tapping, machined surface implants (using the Brånemark system). 
It was concluded that the self-tapping, screw-shaped implants lead to an excellent 
adaptation of the graft and even compression of the graft towards the residual bone. 
In some circumstances, using residual bone is not suitable for one-stage surgery, for 
instance when the residual alveolar ridge is too small for the fixture to be penetrated 
in both the residual and the grafted bone, allowing compression of the bone graft, or 
when bone grafts are used solely as lateral onlay. Sjöström and colleagues22 report a 
90% survival rate in a total of 192 implants after a 3-year follow-up. Using a delayed 
placement of titanium implants with a turned surface, 29 patients were reconstructed 
with free iliac crest grafts using onlay/inlay or interpositional bone grafts; 25 patients 
remained for the follow-up period. In the same study, a literature survey was also 
conducted, indicating that while the one-stage technique is the most commonly used 
procedure, delayed placement of implants results in a higher survival rate. Triplett 
and Schow30 have shown that the success rate of implants placed in grafted areas 6–9 
months after bone augmentation is higher than when implants are placed 
simultaneously with the grafting procedure. The authors have suggested four 
important and valid factors:
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1. Rigid fixation and a tension-free primary closure of the soft-tissue flap 
minimizes complications that lead to failure. 
2. Most of the grafting failure is due to infections or exposure of the graft to the 
oral cavity because of dehiscence. Early loading of grafts with a transitional 
prosthesis is another potential cause of graft failure. 
3. Success of the placement of endosseous implants in the grafted area is more 
predictable using a delayed surgical procedure. 
4. Failure of individual implants in the grafted bone does not imply failure of the 
bone graft. In most cases there will be enough bone volume after 6–8 months for 
successful implant placement. 
Becktor and co-workers137 have indicated that the trauma caused by a provisional 
maxillary denture opposed by a mandibular dentition, creating force concentration 
rather than force distribution, could induce further trauma to the maxilla. 
Furthermore, the authors have implied that there is an association between unilateral 
mandibular dentition and an increase in implant failure in the maxilla. 
Another method for reconstruction of cranio-maxillofacial defects is through tissue 
engineering. A primary source of mesenchymal stem cells (MSCs) for bone 
regeneration is from adipose tissue to provide adipose-derived stem cells (ASCs)138. 
Sándor et al.139 used autogenous fat from the anterior abdominal wall of a patient 
who had undergone resection of a 10 cm anterior mandibular ameloblastoma. 
Adipose-derived stem cells were isolated and expanded ex vivo. The expanded cells 
were seeded onto a mixture of β-tricalcium phosphate (β-TCP) granules and 
recombinant human BMP-2 as a scaffold. Ten months after reconstruction, dental 
implants were inserted into the grafted site. It was concluded that ASCs in 
combination with β-TCP and BMP-2 offers a promising construct for the treatment of 
large mandibular defects without the need for ectopic bone formation and allowing 
rehabilitation with dental implants139.
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Osseointegration of titanium implants
Osseointegration was defined by Brånemark5 as a direct structural and functional 
connection between ordered, living bone and the surface of a load-carrying implant. 
According to Albrektsson140, establishment of osseointegration is dependent on the 
implant material, implant design, implant surface, status of the bone, surgical 
technique, and implant-loading condition. 
According to Rasmusson69, the most common methods of analysis of the interactions 
between bone tissue and titanium are: 1. descriptive histology using light and/or 
electron microscopy (scanning and transmission electron microscopy (SEM and 
TEM, respectively); 2. quantitative histology using morphometry of ground sections 
for light microscopic analysis; and 3. biomechanical tests such as the push/pull tests 
or removal torque tests, as well as resonance frequency analysis (RFA).
Nygren et al.141 describe the effect of the titanium surface on different biological 
components that come in contact with the surface as soon as the implant is placed 
into the surgical prepared site, as a crucial factor in the healing process. The authors 
describe that the surface influences protein adsorption, platelet adhesion and 
haemostasis, inflammation and osteogenic cell response. Bone regeneration around 
oral titanium implants resembles the healing phases of bone injury or fracture, i.e. 
inflammation, regeneration, and remodelling142. In 1991, Sennerby and co-workers143 
examined the bone-titanium interface in retrieved clinical oral implants. Using light 
microscopy and TEM, the authors observed that the threads of the implant were filled 
79–95% with dense lamellar bone, and that a large fraction of the implant surface, 
56–85%, appeared to be in direct contact with the mineralized bone. In areas of direct 
mineralized bone-titanium contact at the ultrastructural level, mineralized bone 
reached close to the implant surface but was separated by an amorphous layer 100–
400 nm tick. Furthermore, Sennerby et al.144 have shown early bone tissue response 
to titanium implants. Placing titanium implants in rabbit tibia, they observed a 
cellular response after 3 days. Osteoblast-producing osteoids were observed at the 
endosteal surface and elongated mesenchymal cells were present at the site of injury. 
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Some macrophages, but rather few other inflammatory cells, were identified. From 
day 7, multi-nuclear giant cells were observed in direct contact with the implant and 
forming a continuous layer along the surface. Bone formation was first identified at 
day 7 as woven trabecular bone formed from the endosteal surface and extended 
towards the implant surface as a solitary formation. This solitary bone matrix was 
described as a base for surface osteoblasts which produced osteoid in a lamellar 
arrangement. With time the two types of newly formed bone fused and more bone 
filled the threads and became remodelled by bone remodelling units. The authors also 
observed that bone-titanium contact and the bone area in the threads increased with 
time until 6 months after implant placement. 
Osseointegration of titanium implants in autogenous bone grafts
The healing of turned-surface titanium implants into grafted bone has been 
previously studied. Nyström et al.145 performed a histological examination on one of 
a series of patients who had undergone treatment with bone grafts from the iliac crest 
in combination with self-tapping fixtures. The patient had died in an accident 4 
months after the operation. Autopsy specimens from the patient were used to analyse 
the amount of osseointegration after 4 months of healing. The graft from the maxilla, 
including all six implants, was retrieved. A specimen from the donor site was also 
removed post-mortem and prepared for histological examination. The results showed 
no clear distinction between the grafted and the residual bone. Marginal aspects of 
the implant showed signs of resorption while the apical portion of the implants 
seemed to be imbedded in the original maxillary bone. The interface between bone 
and implant was to some extent soft tissue, which reflected a delayed remodelling 
process. In only a small section of the implant circumference was a direct BIC 
observed. At the donor site, there was evidence of new bone formation but the gap 
was not bridged. There was no inflammatory reaction in the soft tissue. 
Lundgren and colleagues29 analysed the bone graft-titanium implant interface of 
titanium micro-implants placed simultaneously or after primary healing of the grafts. 
Histological analysis of micro-implants representing healing periods of 0–6 months, 
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0–12 months (simultaneous placement) and 6–12 months (delayed placement) 
revealed that the delayed micro-implants had more bone within the threads and more 
bone in direct contact with the implant surface compared with simultaneous micro-
implant specimens. Furthermore, histological findings of biopsies without micro-
implants at day 0, and 6 and 12 months post-grafting showed signs of ongoing 
resorption, bone formation and remodelling at 6 and 12 months. Morphological 
measurements of bone areas from these biopsies showed more areas of new bone 
after 12 months of healing compared with 6 months post-healing. The authors could 
show that although titanium micro-implants integrate in free autogenous iliac crest 
bone grafts, when used as either onlays or as interpositional bone grafts, the micro-
implants placed in a delayed procedure showed more bone in the implant interface 
compared with the simultaneous procedure. 
Titanium implant surface topography
According to Albrektsson and Wennerberg146, surface quality of an implant can be 
looked at in terms of mechanical, topographic and physiochemical properties. 
Frandsen and colleagues147 found that the holding power of different screws in the 
cancellous bone of femoral head increases with the length and the diameter of the 
thread. According to Albrektsson148, look alike implants do not necessarily show 
similar long-term clinical results. Moreover while, threaded implants have shown to 
become osseointegrated, non-threaded implants result in patches of BIC interrupted 
by areas with a fibrous tissue contact149. 
A long-term follow-up study150 involving standard Brånemark System fixtures 
revealed implant survival rates of 89% at 5 years, 81% at 10 years and 78% at 15 
years for maxillary fixtures. For fixtures placed in the mandible, the survival rates 
reported were 97% at 5 years, 95% at 10 years and 86% at 15 years. The topographic 
surface of standard Brånemark System fixtures has been described in the literature151 
as machined by turning. 
32
A systemic review152 on implant surface roughness and bone healing has revealed 
enhanced BIC with increasing surface roughness. In 2000, Cooper153 described the 
role of surface topography on osseointegration. The author concluded that increasing 
implant surface roughness does increase the surface area of the implant and that it 
would be an advantage if osseointegration consisted of a cohesive bond between the 
implant and the bone. The author also reported that the implant surface topography 
affected the amount of bone formed at the implant-bone interface. The mechanism of 
endosseous integration has been termed “contact osteogenesis” (bone growth on the 
implant surface) by Davies154, a mechanism that can be divided into three phases: 1. 
osteoconduction, where a migration of differentiating osteogenic cells takes place to 
the implant surface through a connective tissue scaffold; 2. new bone formation, 
which results in a mineralized matrix being laid down on the implant surface; and 3. 
bone remodelling. Albrektsson & Wennerberg146 have defined different surface 
roughnesses as follows: 
✦ Smooth surfaces have an Sa value of <0.5 µm.
✦ Minimally rough surfaces have an Sa value of 0.5–1 µm.
✦ Moderately rough surfaces have an Sa value of 1–2 µm.
✦ Rough surfaces have an Sa value of >2 µm.
They concluded that moderately rough implant surfaces have some clinical 
advantages over smoother or rougher surfaces by showing stronger bone responses.
While surface topography can be changed by either subtractive or additive processes, 
as described by Albrektsson & Wennerberg146, surface treatment with fluoride has 
been shown to enhance the retention of titanium implants fourfold compared with 
implants with machined surfaces in rabbit ulna155. According to Ellingsen156, fluor 
ions have documented activity in bone. This element is known to form fluoridated 
HA or fluorapatite, the latter with improved crystallinity and better resistance to 
dissolution compared with HA. In a study conducted by Ellingsen and co-workers157, 
the fluoride modification of the titanium surface and its effect on bone response was 
investigated by comparing titanium oxide (TiO2)-blasted titanium implants with and 
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without fluoride-modified surfaces. The results showed a significantly higher 
removal torque value for the fluoride-modified implants after 3 months. 
Histomorphometric analysis showed higher BIC for the fluoridated test implants.
Further discussion about different types of implant surface modification is beyond the 
scope of the present thesis. 
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AIMS
The aims of the present thesis were:
To compare the bone tissue response for machined and fluoridated implants with 
increased surface roughness installed in onlay bone grafts in one-stage surgery, using 
histomorphometry and RFA. 
To determine if there are any differences in stability and osseointegration of implants 
with bioactive surface installed in autogenous bone grafts using a simultaneous and a 
delayed approach in test and control groups, respectively.
To evaluate marginal bone-level alterations around moderately rough implants 
installed in block vs. particulate autogenous bone grafts. 
To evaluate and compare the extent of resorption of autogenous bone grafts between 
block and particulate bone by three-dimensional (3D) radiographic examination after 
2 years.
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MATERIALS AND METHODS
Animal studies I and II
Animals and anaesthesia
For the experimental studies I and II, female New Zealand White rabbits were 
chosen. The animals were kept in specially designed rooms and fed with a standard 
diet and water ad libitum. 
Surgery was initiated by sedation with an intraperitoneal (i.p.) injection of Stesolid® 
(Dumex, Copenhagen, Denmark) 1.5 mg/kg. General anaesthesia was administered 
by intramuscular (i.m.) injection of Hypnorm® (Janssen Pharmaceutica, Brussels, 
Belgium) 0.2 ml/kg. In addition, 0.8 ml of local anaesthesia (2% lidocain/epinephrine 
1:80 000; Astra AB, Södertälje, Sweden) was given. Post-operatively, single i.m. 
injections of antibiotics (Intencillin® 2 250 000 IE/5 ml, 0.1 ml/kg body weight; 
LEO, Helsingborg, Sweden) and analgesic (Temgesic® 0.05 mg/kg body weight; 
Reckitt & Coleman, Hull, UK) were given. The healing times for both studies I and II 
were 8 weeks. After completion of healing, the animals were sacrificed by a mixture 
overdose of Rompun® Vet. (Bayer A/S, Animal Health Division, Copenhagen, 
Denmark) 20 mg/ml and Ketalar® (Pfizer AB, Sollentuna, Sweden) 50 mg/ml.
Implants
Screw-shaped titanium implants from commercially pure titanium 9 mm long and 3.5 
mm in diameter were used in Study I. Control implants had a machined surface while 
test implants had a fluoridated surface (OsseoSpeedTM; Astra Tech AB, Mölndal, 
Sweden). 
The same screw-shaped titanium implants with fluoridated surface (OsseoSpeedTM; 
Astra Tech AB, Mölndal, Sweden) and similar dimensions were used in one-stage 
and two-stage surgery protocols in Study II. Fixation of the bone graft in the two-
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stage surgery protocol was achieved by using a titanium mini-screw 5 mm long and 2 
mm in diameter.
Surgery protocols
Study I
Eight adult (8–9-month-old) female New Zealand White rabbits were used in this 
study. The proximal tibial metaphysis on both sides was used as experimental sites. 
The autogenous bone grafts were harvested from the calvarial bone. Surgery was 
performed under aseptic conditions and was initiated by making an incision and 
raising a sub-periosteal, full-thickness flap. A trephine bur was used to harvest a disc-
shaped bone graft 8 mm in diameter and 2 mm thick from the lateral aspect of the 
sagittal suture of the calvarium, with care taken not to penetrate the dura. After bone 
harvesting, the donor site was sutured in layers using Vicryl 5.0 (Ethicon®; Johnson 
& Johnson, Livingston, Scotland) and the skin using Monocryl 3.0 (Ethicon®; 
Johnson & Johnson, Livingston, Scotland). The proximal tibial methaphyses were 
exposed bilaterally through a skin and fascia-periosteal flap. A 3.2 mm hole was 
drilled in the centre of each bone graft, using a 3.2 mm twist drill. The hole and the 
proximal tibial metaphysis were then prepared for a dental implant (Astra Tech AB, 
Mölndal, Sweden) 9 mm long and 3.5 mm in diameter with a machined surface as 
control and a fluoridated surface (OsseoSpeedTM; Astra Tech AB, Mölndal, Sweden) 
as test. Test and control sides were randomized. All implants were installed with good 
primary stability. Cover screws were placed and fascia-periosteal flaps were sutured 
in the same way as the donor site. After 8 weeks of healing, the animals were 
sacrificed by a mixture overdose of Rompun® Vet. (Bayer A/S, Animal Health 
Division, Copenhagen, Denmark) 20 mg/ml and Ketalar® (Pfizer AB, Sollentuna, 
Sweden) 50 mg/ml. The right and left tibia and excess tissue were removed.
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Figure 3. An implant placed in a one-stage 
surgery protocol
Study II
Six adult female New Zealand White 
rabbits were used in this study. The 
autogenous bone graft was harvested 
from the calvarium and placed on the 
tibial metaphysis as the recipient site, as 
described in Study I. However, the bone 
graft surgery was conducted on two 
occasions to acquire specimens with 
different healing times. During the initial bone harvesting procedure, the bone graft 
was fixed on the tibial bone by means of a mini-screw 5 mm long and 2 mm in 
diameter. The fascia-periosteal flaps were then sutured in layers using Vicryl 5.0 
(Ethicon®; Johnson & Johnson, Livingston, Scotland) and the skin using Monocryl 
3.0 (Ethicon®; Johnson & Johnson, Livingston, Scotland) representing the control 
site. 
After 8 weeks, a second bone graft from the other side of the calvarium was 
harvested and directly placed on and fixed to the tibial bone by a fluoridated implant 
3.5 mm x 9 mm (Astra Tech AB, Mölndal, Sweden) on the other tibial metaphysis, 
representing the test site.
During the same surgery, the fixation screw on the control side, which by this time 
had undergone 8 weeks of healing, was removed. After preparation using the same 
specifications as for the test site, a 3.5 mm x 9 mm OsseoSpeed® implant (Astra Tech 
AB, Mölndal, Sweden) was installed (control site). Therefore, the implants placed in 
healed bone grafts represented control sites and two-stage surgery, while the test sites 
were operated using a one-stage surgery protocol. 
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After another 8 weeks, the animals were sacrificed by a mixture overdose of 
Rompun® Vet. (Bayer A/S, Animal Health Division, Copenhagen, Denmark) 20 mg/
ml and Ketalar® (Pfizer AB, Sollentuna, Sweden) 50 mg/ml.
The experimental studies were approved by the local ethic committee for animal 
research (DNR: 128–2007).
Figure 4. Two-stage vs. one stage surgery 
protocols.
Specimen preparation
Studies I and II
Directly after the sacrifice of the animals, the implants and surrounding tissue were 
removed en bloc and immediately fixed by an immersion of 4% buffered 
formaldehyde. The specimens were later dehydrated in a graded series of ethanol and 
embedded in light curing resin (Technovit® 7200 VCL; Kulzer and Co., Wehrheim, 
Germany). A sawing and grinding technique (Exakt® System; Apparatbau, 
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Norderstedt, Germany) was used to make approximately 10 µm thick ground sections 
of each specimen. The sections were then stained with 1% toluidine blue and 
pyronin  G.
Analysis and calculations
Studies I and II
The sections were viewed and analysed in a light microscope (Nikon Eclipse 80i; 
Tekno Optik AB, Göteborg, Sweden) using 1.8–100x magnification, connected to a 
personal computer with software for morphometry (Easy Image Measurements 2000; 
Tekno Optik AB, Göteborg, Sweden). Morphometrical measurements of the 
following dimensions were made:
1. Bone-to-implant contact in the grafted bone.
2. Bone-to-implant contact in the total amount of bone (bone graft and residual 
bone).
3. Total bone structure within a region of interest (ROI).
The above calculations were done by measuring the following parameters:
1. Implant length in the grafted bone.
2. Bone-to-implant contact of the grafted bone.
3. Implant length in the residual bone.
4. Bone-to-implant contact of the residual bone. 
To calculate the total BIC, parameters (2) and (4) were added together. These 
measurements were performed at both sides of the longitudinal axis of each implant 
and a mean value was calculated for each implant. Bone area within an ROI was 
measured by drawing a vertical line about 1.0 mm from the outer border of each 
implant surface, parallel to the longitudinal axis of each implant including seven 
implant threads within the grafted area. 
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Resonance frequency analysis: implant stability measurements
For performing a non-invasive, in vivo assessment of implant stability, a resonance 
frequency measurement method has been proposed by Meredith and co-
workers158,159. The principle of this method is to attach a transducer to an implant 
fixture either directly or through a transmucosal abutment. Via a sinusoidal signal, the 
transducer is vibrated and implant stability is assessed by measuring the resonance 
frequency of the transducer. There is a clear correlation between resonance frequency 
and the exposed height of the fixture. The transducer is also sensitive to the stiffness 
of the surrounding tissue. According to Rasmusson69, the technique measures the first 
bending resonance frequency of a small transducer that is attached to a fixture or 
abutment. Rasmusson reports that the resonance frequency is dependent on two 
factors: the stiffness of the implant-bone system, and the height of the transducer 
above the marginal bone level. 
Studies I and II
As a non-invasive implant stability measurement, RFA was used according to the 
method described by Meredith et al.159. Resonance frequency analysis was performed 
in all animals at the time of surgery and at the end of the experiment using OsstellTM 
(Integration Diagnostics AB, Göteborg, Sweden). A transducer was attached and 
registrations were made perpendicular and longitudinal to the long axis of each 
implant. Mean values for the test and control implants were calculated. 
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Clinical and radiographic studies III and IV
Patients
Study III
 Fifteen patients (two men and 13 women, mean age 58 years, range 35–75 years) 
with severe resorption of the maxilla were reconstructed with autogenous bone grafts 
from the anterior iliac crest and rehabilitated with oral implants with full fixed 
bridges. 
Study IV
Using the patient group from Study III, eleven edentulous patients (all female) with 
severe resorption of the maxilla were followed up with CT scans taken pre-
operatively, directly after grafting surgery, and 6 and 24 months post-grafting surgery. 
The clinical studies were approved by the local ethics committee for human trials 
(DNR: 19199-11-01).
Pre-surgical examination, inclusion and exclusion criteria
After clinical examinations, the extent of horizontal and vertical bone deficiencies 
was assessed by CT scans. Inclusion criteria were severely resorbed maxilla with an 
anterior crestal width of <3 mm and/or height of <7 mm. Inclusion criteria for 
vertical bone height at the posterior aspect of the maxilla were set at <5 mm. Patients 
smoking fewer than ten cigarettes per day, with no alcohol abuse, and between 20 and 
75 years old were selected. 
Twelve out of 15 patients in Study III were smokers (<10 cigarettes/day) prior to 
treatment. One patient smoked during the period from bone grafting to the abutment 
connection. In Study IV, all eleven patients who were followed up were among those 
who were smokers before the bone grafting procedure. Exclusion criteria were acute 
illness, ongoing chemotherapy, ongoing or recent (within 3 years) radiotherapy and 
i.v. bisphosphonate treatment. 
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Pre- and post-surgical care
At the start of the bone grafting surgery, benzylpenicillin (3 g x 3) or clindamycin 
(600 mg x 3) was given peri-operatively and for the following 24 hours. Patients 
received a prophylactic antibiotic regimen for 10 days after the grafting procedure 
with either phenoxymethylpenicillin (1 g x 3) and metronidazole (400 mg x 3) or 
clindamycin (300 mg x 3).
At the time of implant installation, patients received a single dose of antibiotic, either 
phenoxymethylpenicillin (2 g) or clindamycin (300 mg). The antibiotic cure 
continued for 5 days after implant surgery, using either phenoxymethylpenicillin (1 g 
x 3) or clindamycin (300 mg x 3). As analgesic, acetaminophen with codeine or non-
steroidal anti-inflammatory drug was prescribed for a period of 1–2 weeks after 
surgical procedures. Dentures were not used during the first month following the 
grafting procedure and for 10 days after the implant placement. 
Bone harvesting and preparation
Under general anaesthesia, an incision was made about 2 cm posterior of the anterior 
superior iliac spine on either the right or the left side. A cortico-cancellous block of 
bone from the medial aspect of the iliac crest was harvested by means of a reciprocal 
saw, leaving the lateral part of the iliac crest intact. The incision was sutured in 
layers. To achieve particulate bone (test side), a bone mill (Tessier Osseous 
Microtome (TOM®); Stryker Leibinger GmbH, Freiburg, Germany) was used. 
Harvested cortico-cancellous bone graft was milled down to pieces and mixed with 
platelet-rich plasma (PRP) prepared from withdrawal of whole blood from a 
peripheral vein of the patient.
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Figure 5. A cortico-cancellous  bone being 
harvested from the medial aspect of the iliac 
crest
Bone augmentation of the anterior 
maxilla
Bone blocks as onlay graft (control)
Once a mucoperiosteal flap was raised on 
the maxilla, the recipient site was 
prepared using a small round bur until 
small spots of bleeding were observed. A 
cortico-cancellous bone block harvested 
from the anterior iliac crest was placed on the right side (frontal sub-nasal area) of the 
maxilla. The bone block was fixed to the residual bone by a minimum of two 
titanium screws (6–13 mm in length) to achieve a rigid fixation of the bone graft. 
Particulate bone as onlay graft (test)
On the left side, the particulate bone mixed with PRP was placed onto the recipient 
site. 
No randomization was made for the test and control sides.
To gain full, tension-free soft tissue coverage of the grafted area, an incision was 
made through the periosteum and the flap was elevated in order to cover the 
augmented area. The incision was then sutured using resorbable sutures (Vicryl®; 
Johnson & Johnson AB, Sollentuna, Sweden).
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Figure 6. Bone blocks are fixed by fixation screws on the right side. Particulate bone placed 
on the left side.
Implants
After 6 months of healing, surface-modified oral implants with titanium dioxide 
(TiOblastTM; Astra Tech AB, Mölndal, Sweden) were installed. Eight implants were 
installed in each patient.  After a further 6 months of healing, abutments were placed 
in all cases.
Radiographic examinations
Study III
To measure the marginal bone level, parallel intra-oral radiographs were taken at 
baseline (after completion of the prosthetic treatment), after 1 year and again after 5 
years of loading. There were four dropouts for the 5-year radiographic examination, 
but no implant losses had been reported. 
One observer with long experience in the field of implant radiology performed the 
evaluations of all radiographs. The evaluations were conducted by measuring the 
marginal bone height and bone-level alterations over time at the mesial and distal 
surface of each implant between a reference point and the bone level of each implant. 
45
The highest point of the vertical section of each implant at the mesial and distal 
surfaces was chosen as reference point. Signs of radiographic changes at the BIC 
zones, indicating loss of osseointegration, and signs of bone loss related to 
mechanical components of the implants were registered. Bone-level measurements 
were conducted to the nearest 0.1 mm by means of a magnifying lens x7. A mean 
value of the mesial and distal measurements was calculated per implant. To determine 
the error of radiographic measurements, double recordings of one randomly selected 
implant per patient from the 5-year follow-up examination were performed and the 
mean difference between the two readings was set as the degree of marginal bone 
resorption.
Study IV
To establish 3D volumetric changes of the bone grafts, we performed CT 
examinations using a CT Pace Plus (General Electric, Milwaukee, MI, USA) for 2 
mm axial scans. Scans were taken within 1 month of the grafting procedure (the first 
post-operative CT examination) and after 6 and 24 months. All CT scans were taken 
at one hospital, following the same procedure and analysed by one person. The total 
volume of the grafted areas was measured separately at the test and control sides 
using axial and sagittal images. The two types of bone grafts were identified on the 
lateral aspect of the anterior maxilla. Next, the volume of each bone graft was 
calculated by measuring the following dimensions: thickness of the bone graft in a 
bucco-palatal aspect, and vertical height and horizontal length in an anterior-posterior 
direction of the grafted areas. To reduce the error in the radiographic measurements, 
three different CT sections at each dimension were selected. In order to be as 
consistent as possible, we used sections showing the largest amount of bone in all 
dimensions. Furthermore, we used a drawing function for measurement of distance, 
to manually plot the ranges in all three sections of each dimension. In this fashion, 
the mean value for each dimension was calculated, and multiplied to obtain a value in 
cubic mm. 
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Based on clinical experience, we suspected that the width of the bone grafts was 
more prone to resorption, therefore the results of changes in the bucco-palatinal 
aspect were presented separately.
Statistics
Studies I–IV
The Wilcoxon signed-rank test was used for statistical analysis and a difference 
between the two groups was considered significant if p<0.05.
 
47
RESULTS
Integration of moderately rough fluoridated implants in 
autogenous bone grafts 
 Studies I and II
The aim of the first animal study (Study I) was to establish whether there would be 
any differences in bone response between machined, and moderately rough and 
fluoridated implants with increased surface roughness when placed in autogenous 
bone blocks using a one-stage surgery protocol.
Study II aimed to answer if there are any differences in bone tissue response to 
implants with increased surface roughness when simultaneously placing them with 
block bone grafts or when using a delayed surgery protocol after 8 weeks of graft 
healing.
Clinical observations
Because of unexpected death of one animal in the first study, the total number of 
animals was reduced to seven. In Study II, all six animals could be analysed through 
the planned time protocol. 
At the time of sacrifice and specimen preparation, all bone grafts had healed and 
integrated into the residual bone with smooth and mature texture. In Study I, the RFA 
showed statistically higher stability for the implants with moderately rough 
fluoridated surface (test surface), both at the time of implant placement and after 8 
weeks of healing. In Study II, RFA results were higher for implants when using a 
delayed approach at the time of implant installation. However, the difference between 
control and test sides had levelled out by the time of sacrifice. 
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Histological observation
Cross-sections of experimental sites in each specimen showed implants well 
integrated into both residual and grafted bone. Although grafted bone tissues were 
well integrated into the residual bone, a demarcation could be observed between the 
two. This demarcation was more distinct in Study II when placing implants at the 
time of bone augmentation, hence with shorter healing time for the bone grafts prior 
to specimen preparation. With higher magnification, the grafted area appeared to be 
more mature bone when using a delayed surgical protocol (control). 
Histomorphometry
In Study I, histomorphometry revealed that the BIC within the grafted area as well as 
total bone (grafted bone + residual bone) was higher for the fluoridated, rough (test) 
compared with machined (control) implants. The difference was statistically 
significant, with p<0.05. 
In Study II, results comparing the same type of moderately rough implants installed 
in autogenous bone blocks in a simultaneous procedure (test implants) with same 
type of implants installed in healed bone grafts (control implants) showed a tendency 
for a higher BIC for the control side (n.s.). Results for total BIC were almost identical 
for test and control sides.
Marginal bone-level alterations and three-dimensional 
analysis of volumetric change in autogenous bone grafts
 Studies III and IV
The purpose of the third study in this thesis was to: 1. assess the marginal bone-level 
alterations around moderately rough oral implants (TiOblastTM; Astra Tech AB, 
Mölndal, Sweden); 2. evaluate whether there is any difference in marginal bone-level 
alterations between implants placed in autogenous block (control implants) or 
particulate bone (test implants); and 3. whether there is any difference in stability 
between test and control sites as measured by RFA. 
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Study IV aimed to investigate volumetric changes of autogenous bone grafts placed 
as lateral onlay in the anterior maxilla. The extent of resorption of the grafted bone 
after 2 years was investigated. Furthermore, we wanted to establish whether there is 
any difference in the amount of resorption between autogenous block and particulate 
bone. 
In Study III, radiographic findings revealed a tendency towards more marginal bone 
resorption from the reference point at sites augmented with autogenous block bone 
(control) at baseline, after 1 year and again after 5 years. However, the difference 
between test and control sides was not statistically significant. Resonance frequency 
analysis showed almost similar results at implant installation between test and control 
sides and a tendency for higher values for the implants placed in particulate bone 
(test) at the time of abutment surgery and after 1 year in function. After 3 years, the 
difference in RFA value had levelled out between the test and control sides. No 
statistically significant difference was observed at any time during the follow-up 
period.
In Study IV, the volumetric change, measured by CT, showed extensive resorption of 
both particulate (test) and block (control) bone grafts after 24 months. The amount of 
volume reduction appeared to be higher on the test side (81.1±8.3%) augmented with 
particulate bone, compared with the control side (77.8±5.2%) augmented with block 
bone, but the difference was not statistically significant. 
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Table 1. This table shows the volume reduction of the grafted bone
0
1000
2000
3000
4000
5000
First post grafting 6 months 24 months
K
ub
ic
 m
m
Time period
Test (Particulate bone) Control (Block bone)
51
DISCUSSION
Animal studies
The results showed significantly higher BIC and implant stability when using 
fluoridated surface-modified implants installed in autogenous bone grafts compared 
with implants with machined surface. Although factors such as stability of the grafted 
bone, healing time, primary stability of the implant and surface dimensions of the 
implant are crucial factors for successful integration and stability of both the grafted 
bone and the implant, surface configuration and properties of the implant seem to 
play a crucial role in osseointegration.
According to Sennerby and Meredith160, the main determinants of implant stability 
are: 1. The mechanical properties of the bone tissue at the implant site; and 2. how 
well the implant is engaged with that bone tissue. Furthermore, the authors state that 
the mechanical properties of bone are determined by the composition of the bone at 
the implant site and may increase during healing because soft trabecular bone tends 
to undergo a transformation to dense cortical bone in the vicinity of the implant 
surface. Therefore, stability of the grafted bone can be related to the mechanical 
properties of the bone tissue at the implant site. In addition, it has been shown by 
Philips and Rahn161 that bone grafts need to be stabilized for predictable graft 
survival and that rigid fixation facilitates the preservation of the bone graft volume, 
probably because this creates an appositional phase earlier and, consequently, 
improved osteoconduction161. 
In studies I and II, rigid fixation of the bone graft was gained by placing the implants 
bicortically through the cortical layers of the graft and the thicker outer cortex of the 
tibial bone. By doing so, good primary stability of the implants was achieved in all 
animals. By the time of sacrifice, the bone grafts had fully integrated with the tibial 
bone with smooth surface and rounded edges, displaying ongoing remodeling. 
Consequently, we conclude that autogenous bone block can be rigidly fixed by means 
of an implant in one-stage surgery. However, it must be noted that in this study, since 
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the bone grafts were placed and fixed on the tibial bone, the grafts could easily be 
stabilized by one implant. This procedure does not fully reflect the clinical situation 
where the alveolar crest has undergone extensive resorption resulting in inadequate 
alveolar width and a need for bone augmentation with lateral onlay grafts. However, 
when vertical bone augmentation is needed, as described by Nyström and 
colleagues133, the results of studies I and II may be applicable to understanding the 
healing process. 
A disadvantage of using the animal model we used in studies I and II is that other 
factors such as primary wound closure, loading due to masticatory forces, the 
preservation of keratinized soft tissue and other factors that are relevant within the 
oral cavity milieu, cannot be taken into account when the bone grafting procedure is 
performed on the tibial bone. Another aspect that should be taken into consideration 
in the animal models used in studies I and II, is use of IM bone as the bone graft. 
Bone grafts from different donor sites and different origins have been debated by 
some authors who relate the quality of IM bone graft for better volume maintenance, 
to different factors as described earlier in this thesis. 
The most important limitation of the animal studies must be the low number of 
animals used. Even so, we were able to show statistically significant differences 
between the test and control sides in Study I. The results in Study I are clearly in 
favour of fluoridated implants and seem likely to be due to the fluoridated surface 
configuration of the test implants. Previous studies investigating the influence of 
fluoridated implant surface in non-grafted bone show favourable results for this 
surface modification. Using the same animal model, Ellingsen and colleagues157 
compared TiO2-blasted titanium implants with and without fluoride modification with 
respect to BIC, bone area in threads, and removal torque resistance in rabbit tibia. 
The authors showed results in which the mean BIC value for all threads after 1 and 3 
months of healing was significantly higher for the fluoridated compared with control 
implants. The authors also showed significantly higher bone area filling the threads in 
the best three consecutive threads as well as bone area in all threads after a 3-month 
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healing period. Removal torque in the same study displayed a higher mean value after 
1 and 3 months, the latter being statistically significant. Other experimental studies 
have presented similar results with fluoride-modified implant surfaces. Abrahamsson 
and co-workers82 showed a significantly higher degree of BIC within a defect area at 
fluoride-modified implants than at implants with only titanium dioxide-blasted 
surfaces. Therefore, our results from Study I are in accordance with previously 
conducted studies performed in non-grafted bone. 
 
In Study II, we sought to examine whether there are any differences in 
osseointegration of oral implants placed in autogenous onlay bone grafts in one-stage 
surgery vs. a two-stage surgery protocol. The focus was solely on implants with 
moderately rough fluoridated surface and our intention was to investigate whether 
these implants would osseointegrate to the same extent when installed simultaneously 
with the graft as when installed using a delayed procedure. Previous studies using 
implants with turned surface have shown results in favour of a delayed procedure. 
Rasmusson and co-workers162 showed a significantly higher degree of BIC in the 
grafted part of the bone, with the delayed procedure. Resonance frequency analysis 
results were also significantly higher for implants placed after 8 weeks of healing. It 
was concluded that a delayed placement of titanium implants in autogenous onlay 
bone grafts results in greater implant stability because of a greater degree of bone 
formation and more bone contact with the implant. Using rabbit mandible as the 
recipient site, Shirota et al.163 studied HA implants in grafted bone harvested from 
rabbit ilium. The authors observed that new bone formation is delayed when implants 
are placed immediately at the grafting procedure. Moreover, they report that a 
delayed placement (after 90 days) of HA-coated implants resulted in a greater amount 
of bone bonding to the implant surface. Using RFA, Sjöström and colleagues164 
compared implants placed in grafted and non-grafted normal bone in the maxilla. 
They present results in which 8% of the implants were lost when placed in the grafted 
bone vs. 1% in non-grafted bone. The bone grafting procedure was either 
interpositional grafting following a LeFort I osteotomy if patients had a reversed 
inter-maxillary relation (five patients), or onlay bone grafting because of thin alveolar 
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crest and loss of vertical bone height (24 patients). In grafted patients, the bone grafts 
were harvested from the iliac crest and the implants were placed 6 months after the 
grafting procedure. Another group consisting of ten patients with edentulous but non-
grafted maxillae were included in that study. Two-stage surgery for the implant 
placement was chosen and the healing time for the implants before loading was 6–8 
months depending of their primary stability. The results, using RFA, showed that 
when applying a delayed surgical procedure in bone grafting, implants placed in 
grafted bone after a minimum primary healing period of 6 months can be as stable as 
implants placed in non-grafted maxillary bone164. 
Our results from Animal study II showed a tendency of greater amount of BIC in the 
grafted bone area with the two-stage surgery protocol. This is in line with previously 
described studies. However, the difference in BIC was not statistically significant. 
Moreover, the difference between test and control implants for total BIC and for bone 
area within an ROI was nearly the same. The data in the present thesis could be 
interpreted as either resulting from insufficient sample size or indicating that a higher 
amount of BIC can actually be achieved with implants with a rough, fluoridated 
surface. If the latter is true, this would be in line with Animal study I, in which we 
showed that fluoridated titanium implants achieve greater BIC and higher implant 
stability in terms of RFA when placed in an autogenous bone graft.
Although RFA results at implant placement were higher for the group undergoing 
two-stage surgery (controls), the values were almost identical after 8 weeks of 
healing. The deviation in RFA value at implant placement could be attributed to the 
non-incorporated graft and consequently lower implant stability for the group 
operated with one-stage surgery (test group); however, once the grafted bone was 
healed and incorporated into the residual bone, RFA results proved to be as high as 
for the control group. 
The exact role of fluoridation cannot be explained regarding the healing process in 
these animal studies; however, fluoridation of titanium implants could have an 
influence on the healing process of the graft. Any superiority of fluoridated implants 
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is probably not entirely due to their topographic features but could also be related to 
chemical composition. It has been documented that NaF can increase the proliferation 
rate, and the alkaline phosphatase content of bone cells in vitro165. It has also been 
reported in the literature that fluoride may act directly on osteoprogenitor cells and 
undifferentiated osteoblasts which synthesize growth factors rather than stimulating 
the proliferation of highly differentiated osteoblasts166–168. To my knowledge, there is 
no evidence that there exists a true chemical bond between fluoride ions and bone 
cells when using fluoridated implant surfaces. However, it may be true that 
fluoridation of implants stimulates mesenchymal proliferation of stem cells and could 
induce more rapid bone healing along the bone-titanium implant interface.
Clinical and radiographic studies
In Study III, the intention was to investigate whether there are any differences in 
marginal bone alterations between implant sites previously augmented with 
autogenous block, and particulate bone. The radiographic examinations were 
conducted at baseline (i.e. just after completion of the prosthetic supra-construction), 
and after 1 and 5 years of loading. However, clinical evaluation of implant stability 
by means of RFA was performed at the time of implant installation, at abutment 
surgery, and after 1 year and 3 years in function. Consequently, there is no evaluation 
of implant stability at 5 years that could be correlated to the radiographic findings. 
This is clearly a limitation of this study. However, if we separate the results from our 
radiographic findings and implant stability measurements, we can conclude that since 
the difference in marginal bone alterations at the implant sites between particulate 
bone (test) and block bone (control) is insignificant, no obvious guidance can be 
given as to whether to use particulate or block bone as lateral onlay in cases of 
severely resorbed and thin maxillae. 
Furthermore, we noted in Study III that the marginal bone-level alteration for test and 
control sites could not be distinguished in the period between 1 year and 5 years of 
loading. Most of the marginal bone resorption took place during the first year of 
loading and only a limited recession of the marginal bone occurred between 1 year 
and 5 years in function. This is in line with the findings of Nyström et al.133 who 
showed that most of the reduction in height of the grafted bone occurs between 3 
months and 1 year. They found that the reduction of the bone height was insignificant 
during the first 3 post-operative months, but it increased and became statistically 
significant between 3 and 6 months. The reduction in height continued to be 
significant during the following 6 months but levelled out and had become 
insignificant by the second follow-up. Nyström et al.’s follow-up study133 lasted 24 
months and was conducted using CT examinations rather than intra-oral radiographic 
imaging as used in Study III in this thesis. Additionally, bone grafts were in the shape 
of a horseshoe from the iliac crest and placed on the alveolar ridge as an onlay and 
fixed using a self-tapping fixture. Despite the fact that our method in Study III differs 
from that employed in the study by Nyström et al.133, convincing parallel conclusions 
can be drawn to state that most of the reduction in graft height occurs during the first 
year. A plausible cause for the marginal resorption is the remodelling of the bone 
graft during the initial healing phase.
It can be argued that block bone grafts that are cortico-cancellous could be more 
stable assuming that they are rigidly fixed. On the other hand, the revascularization 
process takes longer compared with particulate bone. The particulate bone used in 
this study was also cortico-cancellous. It can be assumed that because of its 
particulate nature, the revascularization process could start earlier, hence more rapid 
maturation and perhaps incorporation of the grafted bone into the residual bone could 
occur. However, particulate bone grafts could be more susceptible to lateral and even 
occlusal forces during masticatory function. Clinical circumstances should act as a 
guide to the type of bone graft best suited for the individual case. For instance, if 
there are extensive areas with ridge discontinuities and valleys on the lateral alveolar 
bone, bone blocks may be difficult to fit and may not remain stable even with fixation 
screws. In these cases a cortico-cancellous bone graft can be milled to pieces and 
more easily be fit to the defected areas while at the same time augmenting the lateral 
alveolar ridge for implant placement. However, whenever a more continuous and 
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even alveolar bone is present, a block bone graft can be chosen for lateral 
augmentation. 
Another issue that needs to be addressed in Study III is the survival and stability of 
the implants in grafted bone. It was reported8 that only two fixtures in two patients 
were found to be mobile at the abutment surgery and consequently removed. 
Resonance frequency analysis revealed no significant differences between test and 
control implants during the 3-year observation period. In another study, conducted by 
Rasmusson and colleagues169, evaluation of TiO2-blasted implants integrated in 
grafted and non-grafted maxillary bone was performed by RFA at implant placement 
and abutment surgery 6 months later. The implants were placed in the following 
groups: onlay block graft, onlay particulate graft, particulate sinus inlay, 
interpositional block graft, and non-grafted maxilla. No significant differences were 
observed between the first and second measurements; however, implants placed in 
interpositional bone grafts exhibited a significantly lower RFA value compared with 
other groups. The implants used in Study III were surface-modified titanium implants 
with titanium dioxide (TiOblastTM; Astra Tech AB, Mölndal, Sweden). Our results are 
to some extent in line with the results presented by Rasmusson et al.169. Whether or 
not titanium dioxide surface modifications used in our study had any effect on the 
results remains unknown because the same implant type was used on both test and 
control sides. However, it should be added that the moderately rough TiOblastTM 
implants used in our study have an Sa value of 1.1 µm170. Moderately rough surfaces 
have previously been described by Albrektsson & Wennerberg146 to exhibit stronger 
bone response. It has also been reported in the literature that TiOblastTM, like 
OsseoSpeedTM, has micro-threads which have been clinically documented to maintain 
bone level better compared with implants without micro-threads171. De Bruyn and 
colleagues172 have reported a total survival rate of 100% during a 3-year follow-up of 
immediate function of seven to nine Astra Tech TiOblastTM implants placed in 25 
patients. The authors did not exclude patients with smoking habits. Based on 
individual implants, a mean bone loss of 0.16 mm was reported between 3 months 
and 1 year. Only 3.5% of the implants showed bone loss above 1 mm.  According to 
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the report, abutments were placed in a one-stage procedure and fixtures were 
functionally loaded on the day of surgery with a ten-unit provisional bridge. In 
another study, by Steveling and co-workers173, the same type of TiO2-blasted 
implants were used for treatment of single-tooth and partial edentulism in the 
maxilla. The implants were loaded after 3 months of healing and were followed up 
for 5 years. No implants were lost during the observation period. The average 
marginal bone loss was reported to be 0.5±0.7 mm after 1 year, 0.6±0.7 mm after 3 
years and 0.9±1.6 mm after 5 years. 
It can be concluded from Study III and previously reported studies that marginal bone 
loss and survival of titanium implants is dependent on factors such as implant design, 
surface structure and time of loading. The type of autogenous bone graft, i.e. block or 
particulate, does not seem to affect the prognosis of the implants placed within the 
grafted area.
In Study IV, we studied the volumetric changes of autogenous bone grafts in the form 
of lateral onlay block (control) and lateral onlay particulate bone (test) grafts over a 
period of 2 years. To obtain a 3D picture of the grafted area, we used CT as the 
radiographic method of choice. Computed tomography scans were taken within 1 
month after the grafting procedure (the first post-grafting CT) and after 6 and 24 
months. To my knowledge, there have been only a few prospective or retrospective 
long-term follow-up studies evaluating the extent of volumetric changes in onlay 
autogenous bone grafts. 
Changes in the volume and density of calvarial split bone grafts after alveolar ridge 
augmentation were studied by Smolka et al.174. In their study, 15 patients underwent 
augmentation of the alveolar ridge by calvarial autogenous bone grafts. Seven 
patients had mandibular reconstruction, another seven received maxillary 
augmentation and one was subjected to both mandibular and maxillary 
reconstruction. Post-operative CT scans were taken immediately after the grafting 
procedure and before implantation after a post-operative period of 6 months in all 15 
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patients. In five patients, additional follow-up was performed after 1 year. The 
authors report a mean average volume of 83.8% for all transplants (51 calvarial 
bone), corresponding to a mean volume reduction of 16.2% after 6 months. In the 
patient group with 1-year follow-up (26 grafts in five patients), the mean volume 
reduction was 10.7% after 6 months and 19.2% after 1 year. 
In Study IV, results presented by us after 6 months showed a volume reduction from 
4,842.7±1,521.4 mm3 at first post-grafting CT examination to 1,645.2±565.3 mm3 
after 6 months on the test side augmented with particulate bone. On the control side 
augmented by block bone, the volume was reduced from 4,835.5±1,005.6 mm3 at the 
first post-grafting CT examination to 2,999.3±1,452.6 mm3 after 6 months. At the 24-
month CT examination, the bone graft volume was 848.6 ± 324.3 mm3 (test side) and 
1,065.6±306.4 mm3 (control side). Hence, there was a continuing reduction of the 
grafted volume. However, most of the reduction took place during the first 6 months.
Our results from Study IV and the results presented by Johansson et al.27, who also 
used autogenous bone from the iliac crest, show extensive volume reduction from 0 
to 6 months. It has been reported in the literature that IM bone grafts retain volume 
better compared with grafts with an EC origin111. In a study by Ozaki & Buchman114, 
volume maintenance of onlay bone grafts in the craniofacial skeleton was evaluated. 
Twenty-five New Zealand rabbits were used and three graft types were placed onto 
each rabbit cranium: Cortical bone graft of membranous origin. Cortical and 
cancellous bone graft of EC origin were compared. The authors showed a 
significantly greater resorption rate in the cancellous EC bone graft compared with 
either the cortical EC or the cortical membranous bone grafts. In addition, there was 
no significant difference in resorption rates between the EC and membranous cortical 
bone grafts. The authors concluded that cortical bone grafts are the superior onlay 
grafting material.
The embryologic origin of the grafted bone has by some publications been pointed 
out to be a factor in volume maintenance114. Authors such as Kusiak and co-
workers117 have discussed the role of the revascularization process. They have shown 
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that IM bone revascularizes more rapidly compared with EC bone. According to 
Wong & Rabie175, despite the fact that EC bone taken from the iliac crest is more 
cancellous than IM bone, it is conceivable that the difference in the revascularization 
process is more dependent on the extracellular matrices and their content of 
angiogenic mediators and other growth factors than just on the 3D osseous 
architecture of the grafted bone. The authors have related the lack of volume 
maintenance of EC bone grafted into the host IM bone to lack of integration and 
incorporation. Furthermore, Rabie and colleagues176 have identified the cells 
involved in the healing of the autogenous IM and EC bone grafts in the skull of 18 
rabbits. In IM bone, they observed preosteoblasts, osteoblasts and osteocytes with no 
cartilage intermediate stage. By contrast, in EC bone, they observed chondroblasts 
and chondrocytes.
It is clear that when EC bone from the iliac crest is used, the volume of the grafted 
bone is extensively reduced. However, to the best my knowledge, it has not been 
established how long the resorption process continues. There are some studies that 
have reported reduction in grafted bone height. Verhoeven and co-workers177 claim a 
decrease of ca. 25% in the overall height of the graft during the first 6 months. Swart 
& Allard178 report a 44% decrease of the grafted bone height after 5 years in 26 
patients who received cortico-cancellous bone from the iliac crest. In spite of these 
reports, few 3D volumetric measurements have been accomplished to assess volume 
reduction of autogenous onlay bone grafts in long-term follow-up studies. Sbordone 
et al.179 have studied volume changes of autogenous bone grafts after alveolar ridge 
augmentation of atrophic maxillae and mandibles. In their study, two donor sites were 
utilized for the grafting procedure: the mandibular parasymphysis and the iliac crest 
area. The authors report an average resorption of 42% when the onlay was positioned 
in the anterior maxilla (iliac crest graft) and 46% when the onlay was positioned in 
the posterior maxilla (chin graft). In the mandible, resorption amounts of 31% and 
59% were observed when onlay grafts (iliac crest) were positioned in the anterior and 
posterior mandible, respectively.
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Table 2. This table depicts the results from studies conducted on volume changes of 
autogenous onlay bone grafts from the iliac crest
Table 3. This table represent the mean reduction of the reported results from different 
studies 
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Recently, a 6-year follow-up study180 on volume changes of autogenous bone grafts 
harvested from the iliac crest was reported. Both maxillary and mandibular onlay 
grafts were examined. Computed tomography was used to analyse volume reduction. 
After 6 years, a reduction of 87% was recorded for blocks grafted in the mandible. 
For maxillary grafts, complete resorption of the grafts (mean 105.5%) was noted. No 
implant failure was recorded. 
In Study IV of the present thesis, the volume reduction of the particulate bone graft 
(test) after 24 months was 81.1±8.3%. On the control side augmented by block bone, 
the grafted volume decreased by 77.8±5.2%. The difference between test and control 
sides was not statistically significant. This could be due to either insufficient sample 
size, or to there being no difference in fact in resorption pattern between particulate 
and block bone.
Whether our results regarding volume reduction were affected by previous smoking 
habits of the patients remains unknown. Other factors such as gender and the use of 
dentures after 1 month following the grafting procedure and 10 days after implant 
placement could have had some effects on the resorption pattern. 
Changes in bone graft width were also calculated in Study IV. Our results show a 
reduction in bone graft width at the test side of 51.5±7.5%. On the control side 
augmented by onlay block, the graft was reduced by 49.9±8.1% (n.s.). In the study by 
Nyström et al.133, in which the authors used horseshoe-shaped iliac bone combined 
with Brånemark® fixtures in a one-stage procedure, the reduction in bone graft width 
3 weeks post-operatively was 12.2 mm and after 12 months, 8.7 mm. After 24 months 
the width of the graft was reported to be 8.6 mm, which is almost the same as after 12 
months. It was also reported that most of the bone loss occurred during the first 3 
months. Little reduction took place between 12 and 24 months. Reduction in bone 
graft width was more extensive in Study IV compared with Nyström et al.’s study133. 
This could be due to differences in augmentation technique. With regard to total 
volume change, our results in Study IV illustrate that there is indeed a continuous 
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volume reduction in the grafted bone, whether in the form of a particulate or block 
onlay, over 24 months.  
The fixtures used in Study IV were TiOblastTM implants (Astra Tech AB, Mölndal, 
Sweden). These are made of pure titanium, blasted with titanium dioxide particles 
which make the surface texture moderately rough. Ivanoff and colleagues28 have 
shown significantly higher BIC with TiO2-blasted micro-implants compared with 
turned/machined implants in both maxilla and mandible. They also showed 
significantly higher bone area within threads in mandible in favour of TiO2-blasted 
implants. Gotfredsen et al.181 claimed that TiO2-blasted implants have better 
mechanical anchorage compared with machined surface implants. Although the 
results presented by these authors could not show a statistically significant difference 
in direct BIC, higher resistance with removal torque was demonstrated for the TiO2-
blasted implants. Wennerberg et al.182 show higher removal torque and BIC for TiO2-
blasted implants compared with implants with turned/machined surface. 
Consequently, it can be concluded that implants with higher surface roughness, in the 
form of either fluoridated implants or implants blasted with titanium dioxide, exhibit 
more BIC and stronger resistance to shear force. Although histomorphometrical 
analysis has not been performed in Study IV and the extent of resorption of the 
grafted bone in that study is remarkably high, CT scans show that the implants are 
well imbedded within the grafted and residual bone (Figure 7). 
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Figure 7. This figure shows extensive amount of resorption of the grafted bone, but the 
implants remain imbedded in bone
In conclusion, fluoridated titanium implants have shown to obtain better 
osseointegration within grafted bone. Although we could not show any statistically 
significant difference between one and two-stage surgery when using titanium 
implants with fluoride surface modification, similar bone tissue response and stability 
after 8 weeks was obtained when placing the implants in fresh or healed autogenous 
bone grafts. Furthermore, marginal bone alterations have proved to be more in 
augmented areas (Study III) compared with implants placed in residual bone, as 
mentioned previously in a study by De Bruyn and colleagues172. Before we started 
Study IV, we could find no reports of long-term follow-up of volume changes in 
autogenous onlay bone grafts from the iliac crest in the scientific literature. Results 
from Study IV showed extensive resorption (up to 81.1%) after 24 months, with no 
implant loss. Although total resorption of maxillary onlay grafts has recently been 
claimed by Sbordone et al.180, after 6 years, no implant failure was reported. 
Therefore, I do believe that although a great amount of resorption of autogenous 
onlay bone grafts takes place and that the volume reduction may continue even after 
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24 months, it is still possible to rehabilitate patients with autogenous onlay bone 
blocks from the iliac crest and titanium implants with surface modification. 
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CONCLUSIONS
When using fluoridated moderately rough titanium implants in healed autogenous 
onlay bone grafts, a greater amount of BIC can be achieved compared to implants 
with turned surfaces. Additionally, a higher degree of stability can be achieved with 
fluoridated implants after 8 weeks of healing.
Fluoridated moderately rough titanium implants placed in autogenous onlay grafts 
show no significant differences in osseointegration and stability between fresh and 
healed bone grafts.
No significant difference was shown in marginal bone-level alteration between block 
or particulate bone grafts over a 5-year period. Most of the marginal bone-level 
change took place during the initial healing time and the first year of loading.
No significant differences in resorption were seen between autogenous block and 
particulate bone from the iliac crest. The volume reduction was extensive at 6 months 
and continued until 24 months and may continue to reduce further; however, the 
implants will have a good prognosis when titanium implants with a modified surface 
structure such as titanium dioxide are used.
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FUTURE PERSPECTIVES
In the future, a 10-year follow-up with volume and marginal bone-level 
measurements in the same patient material would be interesting to examine whether 
continued resorption has occurred after 24 months. A clinical evaluation with stability 
measurements would show how many of the implants remain in function after 10 
years. Moreover, other bone augmentation techniques such as the use of growth 
factors in a particulate bone scaffold could be compared with autogenous bone with 
no additive growth factors. The drawbacks with radiographic studies is the difficulty 
in involving patients due to ethical considerations regarding repeated radiation doses 
through CT scans. However, I hope that this problem will be overcome through the 
usage of Cone Beam CT by which one can conduct a prospective study where 
patients can be followed up after 6, 12 and 24 months and hopefully longer.
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